Company news
Simulations Plus, Inc. (NASDAQ:SLP) news
Every Simulations Plus, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
Simulations Plus Releases MembranePlus 3.0
March 10, 2022
Simulations Plus Enters New Collaboration with Leading Animal Health Company
January 13, 2022
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
January 6, 2022
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call
December 20, 2021
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
December 2, 2021
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
November 30, 2021
Simulations Plus Names Sharlene Evans to Board of Directors
November 19, 2021
Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury
November 16, 2021
Simulations Plus Releases GastroPlus® Version 9.8.2
October 28, 2021
Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
October 25, 2021
Simulations Plus Announces the University+ Program
October 21, 2021
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
October 11, 2021
Simulations Plus Receives New Grant Award From the FDA
September 23, 2021
Simulations Plus Releases ADMET Predictor® (X.3)
September 15, 2021
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
August 19, 2021
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
July 12, 2021
Simulations Plus Celebrates 25 Years in Business
July 8, 2021
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
June 28, 2021
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
June 17, 2021
Simulations Plus Uplisted to The Nasdaq Global Select Market®
May 12, 2021
Simulations Plus Releases ADMET Predictor® (X.2)
April 27, 2021
U.S. FDA Renews Licenses of DILIsym Software
April 20, 2021
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
April 12, 2021
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
April 7, 2021
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
March 29, 2021
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
March 16, 2021
Simulations Plus Releases GastroPlus® Version 9.8.1
February 9, 2021
Simulations Plus Enters Agreement with Distributor in China
February 2, 2021
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
January 14, 2021
Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments
January 12, 2021
Simulations Plus Reports Record First Quarter FY2021 Financial Results
January 11, 2021
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides
January 5, 2021
Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call
January 4, 2021
Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report
December 16, 2020
Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer
December 1, 2020
Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results
November 16, 2020
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call
November 9, 2020
Simulations Plus Releases GastroPlus® Version 9.8
October 20, 2020
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
October 13, 2020
Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®
September 29, 2020
Simulations Plus Releases ADMET Predictor® Version 10.0 (APX)
September 15, 2020
Simulations Plus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 10, 2020
Simulations Plus Announces Pricing of $100 Million Underwritten Offering of Common Stock
August 5, 2020
Simulations Plus Announces Proposed Underwritten Public Offering
August 4, 2020
Simulations Plus Reports Third Quarter FY2020 Financial Results
July 9, 2020
Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call
July 2, 2020
Simulations Plus Receives New Grant Award from the FDA
May 28, 2020
Simulations Plus Reports Record Second Quarter FY2020 Revenue
April 9, 2020
Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call
April 2, 2020
Simulations Plus Offers Rapid Response COVID-19 Research Initiative
March 26, 2020